Lucintel Forecasts the Global Enzymatic Stevioside (REBM2) Market is expected to grow with a CAGR of 4.7% from 2025 to 2031
According to a market report by Lucintel, the future of the global enzymatic stevioside (REBM2) market looks promising with opportunities in the food additive and dietary supplement markets. The global enzymatic stevioside (REBM2) market is expected to grow with a CAGR of 4.7% from 2025 to 2031. The major drivers for this market are the increasing